Shengchao Zhang, Jun Yuan, Ruheng Zheng
Oncology Research, Vol.24, No.4, pp. 263-269, 2016, DOI:10.3727/096504016X14666990347392
Abstract Recently, deubiquitinating enzymes (DUBs) are emerging as new regulators in cancer progression. However, understanding of the involvement of DUBs in non-small cell lung cancer (NSCLC) is just beginning. In this study, we
investigated the expression and biological function of ubiquitin-specific peptidase 17 (USP17) in NSCLC progression in vitro and in vivo. We found that the expression of USP17 was higher than in a normal control. We further
efficiently depleted USP17 expression in two different NSCLC cells, A549 and H1299. The anchorage-independent
growth ability of these cells, estimated by soft agar colony formation assay, was significantly More >
Login
Register
